• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Blood Pressure Test Market

    ID: MRFR/LS/14181-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Blood Pressure Test Market Research Report By Product (sphygmomanometers, blood pressure transducers, instrument accessories), By Indication (hypertension, coronary heart disease) and By End User (hospital, clinic, diagnostic center) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Blood Pressure Test Market Infographic
    Purchase Options

    US Blood Pressure Test Market Summary

    As per MRFR analysis, the US blood pressure test market size was estimated at 417.9 USD Million in 2024. The US blood pressure-test market is projected to grow from 456.81 USD Million in 2025 to 1112.58 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 9.31% during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The US blood pressure-test market is experiencing robust growth driven by technological advancements and increased health awareness.

    • Technological advancements in blood pressure monitoring devices are enhancing accuracy and user experience.
    • The largest segment in the market is home healthcare solutions, reflecting a shift towards self-monitoring among consumers.
    • Telehealth integration is rapidly gaining traction, particularly in urban areas, as patients seek convenient healthcare options.
    • The rising prevalence of hypertension and government initiatives promoting preventive healthcare are key drivers of market expansion.

    Market Size & Forecast

    2024 Market Size 417.9 (USD Million)
    2035 Market Size 1112.58 (USD Million)

    Major Players

    Omron Healthcare (JP), Philips (NL), A&D Company (JP), Welch Allyn (US), Microlife (CH), Beurer (DE), SunTech Medical (US), Qardio (US), Withings (FR)

    US Blood Pressure Test Market Trends

    The blood pressure-test market is currently experiencing notable growth, driven by an increasing awareness of hypertension and its associated health risks. As more individuals recognize the importance of monitoring their blood pressure, the demand for both home and clinical testing devices is on the rise. This trend is further supported by advancements in technology, which have led to the development of more accurate and user-friendly devices. Additionally, healthcare providers are emphasizing regular blood pressure checks as part of routine health assessments, contributing to the market's expansion. Moreover, the integration of digital health solutions is transforming the landscape of the blood pressure-test market. Mobile applications and telehealth services are becoming increasingly popular, allowing patients to track their readings and share data with healthcare professionals seamlessly. This shift towards digitalization not only enhances patient engagement but also facilitates timely interventions, potentially reducing the incidence of hypertension-related complications. As the market evolves, it appears poised for continued growth, driven by technological innovations and a heightened focus on preventive healthcare measures.

    Technological Advancements

    Recent innovations in blood pressure monitoring devices are enhancing accuracy and user experience. Smart technology integration allows for real-time data tracking and analysis, making it easier for users to manage their health.

    Increased Health Awareness

    There is a growing recognition of the importance of regular blood pressure monitoring among the population. Educational campaigns and healthcare initiatives are encouraging individuals to take proactive steps in managing their cardiovascular health.

    Telehealth Integration

    The rise of telehealth services is reshaping how blood pressure testing is conducted. Remote monitoring solutions enable patients to connect with healthcare providers, facilitating timely consultations and personalized care.

    US Blood Pressure Test Market Drivers

    Rising Prevalence of Hypertension

    The increasing prevalence of hypertension in the US is a primary driver for the blood pressure-test market. According to the CDC, nearly 47 % of adults in the US have hypertension, which necessitates regular monitoring. This growing patient population creates a consistent demand for blood pressure testing devices and services. As healthcare providers emphasize the importance of early detection and management of hypertension, the blood pressure-test market is likely to experience significant growth. Furthermore, the aging population, which is more susceptible to hypertension, contributes to this trend. The need for effective monitoring solutions is paramount, as untreated hypertension can lead to severe health complications, thereby driving the market further.

    Government Initiatives and Regulations

    Government initiatives aimed at improving cardiovascular health significantly impact the blood pressure-test market. Programs promoting regular health screenings and awareness campaigns about hypertension are being implemented across various states. The US government has allocated substantial funding to support these initiatives, which encourages healthcare providers to adopt blood pressure testing as a routine practice. Additionally, regulatory bodies are establishing guidelines that mandate regular blood pressure monitoring in clinical settings. This regulatory environment fosters a conducive atmosphere for the growth of the blood pressure-test market, as compliance with these guidelines necessitates the procurement of testing devices and technologies.

    Increased Focus on Preventive Healthcare

    The increased focus on preventive healthcare is reshaping the blood pressure-test market. Healthcare providers are increasingly advocating for preventive measures to mitigate the risks associated with hypertension. This shift in focus encourages individuals to undergo regular blood pressure testing as part of routine health check-ups. The emphasis on preventive care is supported by various health organizations that promote awareness about the dangers of uncontrolled hypertension. As a result, the blood pressure-test market is likely to benefit from this trend, as more individuals seek out testing services to monitor their health proactively.

    Growing Demand for Home Healthcare Solutions

    The growing demand for home healthcare solutions is a significant driver for the blood pressure-test market. As patients prefer to manage their health from the comfort of their homes, the need for at-home blood pressure monitoring devices has surged. The market for home healthcare products is expected to grow at a CAGR of 8 % from 2025 to 2030. This trend is particularly evident among older adults who require regular monitoring but may face mobility challenges. Consequently, manufacturers are focusing on developing user-friendly and accurate home testing devices, which is likely to enhance the market's growth prospects.

    Innovations in Blood Pressure Monitoring Technology

    Innovations in blood pressure monitoring technology are transforming the blood pressure-test market. The introduction of wearable devices and smartphone applications that allow for continuous monitoring is gaining traction among consumers. These advancements not only enhance user convenience but also improve data accuracy and accessibility. The market for digital health solutions is projected to reach $200 billion by 2025, indicating a robust growth trajectory. As consumers increasingly seek out these innovative solutions, healthcare providers are also adapting to incorporate these technologies into their practices. This trend suggests a shift towards more personalized and proactive healthcare, further propelling the blood pressure-test market.

    Market Segment Insights

    By Product: Sphygmomanometers (Largest) vs. Blood Pressure Instrument Accessories (Fastest-Growing)

    In the US blood pressure-test market, sphygmomanometers stand out as the largest segment, capturing a significant share of the market. These devices have established themselves as essential tools for measuring blood pressure, making them prevalent in both clinical and home settings. Blood pressure transducers and instrument accessories are also critical components, yet they hold smaller market shares compared to sphygmomanometers. The market is witnessing dynamic growth trends, with blood pressure instrument accessories emerging as the fastest-growing segment. This growth can be attributed to the increasing emphasis on patient monitoring and the need for enhanced accuracy in blood pressure readings. Factors such as technological advancements and rising public awareness of cardiovascular health drive the demand for innovative accessories, leading to their rapid market expansion.

    Sphygmomanometers (Dominant) vs. Blood Pressure Transducers (Emerging)

    Sphygmomanometers remain the dominant force in the US blood pressure-test market, known for their reliability and accuracy in measuring blood pressure. These devices are widely used by healthcare professionals and individuals alike, becoming the gold standard in blood pressure monitoring. Alternatively, blood pressure transducers represent an emerging trend in the market, offering improved diagnostic capabilities and integration with digital health systems. This segment is gaining traction due to the growing adoption of telehealth solutions and advanced monitoring technologies, positioning transducers as vital components for enhancing patient care. As healthcare shifts toward more automated solutions, both segments play crucial roles, with sphygmomanometers serving as the foundation and transducers paving the way for innovative advancements.

    By Indication: Hypertension (Largest) vs. Coronary Heart Disease (Fastest-Growing)

    In the US blood pressure-test market, the hypertension segment holds the largest market share, reflecting its critical importance in managing and preventing cardiovascular diseases. This segment is significantly aided by rising awareness and early detection of hypertension, which are integral to improving patient outcomes. Conversely, the coronary heart disease segment is the fastest-growing, buoyed by increased incidences and a greater focus on preventive healthcare measures. The growth of these segments is driven by several factors, including aging populations and lifestyle changes that contribute to cardiovascular risks. Innovations in blood pressure monitoring technologies and a surge in telehealth services are also reshaping the market landscape. As healthcare systems become more proactive, especially in chronic disease management, the demand for both hypertension and coronary heart disease testing is set to escalate, reflecting an evolving market responding to patient needs.

    Hypertension: Dominant vs. Coronary Heart Disease: Emerging

    The hypertension segment stands as the dominant force in the US blood pressure-test market, primarily due to its widespread recognition as a major risk factor for severe health conditions like stroke and heart attack. It encompasses various testing methods, including oscillometric and invasive techniques, which cater to diverse patient needs. On the other hand, the coronary heart disease segment is emerging rapidly, with innovations and heightened public awareness contributing to its growth. This segment includes advanced diagnostic tools and monitoring solutions. It highlights the shift towards proactive healthcare approaches, emphasizing early intervention and ongoing management of heart health, ultimately improving patient quality of life.

    By End User: Hospitals & Clinics (Largest) vs. Home Care (Fastest-Growing)

    In the US blood pressure-test market, hospitals & clinics hold the largest share among end user segments, reflecting the critical need for these facilities to monitor and manage patient health. Diagnostic centers also contribute significantly, but home care is gaining ground as a result of the increasing preference for remote healthcare solutions. The broad adoption of blood pressure monitors in at-home settings signifies a shift towards convenience and self-management of hypertension, positioning this segment for future growth. The growth trends in the end user segment are driven by several factors, including an aging population, rising incidences of hypertension, and a growing emphasis on preventive healthcare. Home care has emerged as the fastest-growing segment, propelled by technological advancements in blood pressure monitoring devices, which enable patients to track their health proactively. This shift indicates a transformation in patient behavior and healthcare delivery, with an emphasis on at-home care solutions.

    Hospitals & Clinics (Dominant) vs. Home Care (Emerging)

    Hospitals & clinics remain the dominant player in the blood pressure-test market, utilizing advanced monitoring devices and clinical expertise to provide comprehensive care. These institutions are equipped with the latest technology, ensuring precise measurements and prompt responses to any abnormalities. Despite their dominance, home care is viewed as an emerging segment, particularly appealing to patients seeking convenience and autonomy in managing their health. As home care solutions offer user-friendly devices designed for everyday use, this segment is gaining traction, especially among younger demographics who prefer to monitor their health from the comfort of their homes. The shift toward home care is indicative of a broader trend prioritizing patient engagement and personalized healthcare.

    Get more detailed insights about US Blood Pressure Test Market

    Key Players and Competitive Insights

    The blood pressure-test market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as Omron Healthcare (Japan), Philips (Netherlands), and Qardio (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Omron Healthcare (Japan) focuses on integrating advanced digital health technologies into its products, aiming to provide comprehensive health monitoring solutions. Philips (Netherlands) emphasizes its commitment to sustainability and digital transformation, aligning its product offerings with the increasing demand for eco-friendly and connected health devices. Qardio (US) positions itself as a leader in smart health technology, utilizing data analytics to improve user engagement and health outcomes, thereby shaping a competitive environment that prioritizes innovation and consumer experience.

    The market's competitive structure appears moderately fragmented, with numerous players vying for market share. Key business tactics such as localizing manufacturing and optimizing supply chains are prevalent among leading companies. This approach not only enhances operational efficiency but also allows for quicker responses to market demands. The collective influence of these key players fosters a competitive atmosphere where innovation and quality are paramount, driving the overall growth of the market.

    In October 2025, Omron Healthcare (Japan) announced the launch of its latest blood pressure monitor, which incorporates AI-driven analytics to provide personalized health insights. This strategic move underscores the company's commitment to enhancing user experience through technology, potentially setting a new standard in the market for smart health devices. The integration of AI not only improves the accuracy of readings but also empowers users to take proactive steps in managing their health.

    In September 2025, Philips (Netherlands) unveiled a new line of connected health devices designed to integrate seamlessly with its existing health ecosystem. This initiative reflects Philips' strategy to create a holistic health management platform, which could significantly enhance patient engagement and adherence to treatment protocols. By fostering interoperability among devices, Philips aims to solidify its position as a leader in the digital health space, catering to the evolving needs of consumers.

    In August 2025, Qardio (US) entered a strategic partnership with a leading telehealth provider to expand its reach in remote patient monitoring. This collaboration is indicative of the growing trend towards integrated health solutions, where technology and healthcare services converge. By aligning with telehealth services, Qardio enhances its value proposition, offering users a comprehensive approach to health management that is both convenient and effective.

    As of November 2025, the competitive trends in the blood pressure-test market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and deliver superior health solutions.

    Key Companies in the US Blood Pressure Test Market market include

    Industry Developments

    The US Blood Pressure Test Market has seen significant advancements recently, particularly in advancing diagnostic technologies and patient monitoring solutions. Notable developments include Omron Healthcare’s introduction of new innovative devices aimed at promoting home-based blood pressure monitoring, which has gained traction due to increasing consumer health awareness. HillRom Holdings has expanded its product portfolio, focusing on the integration of cloud technologies for remote patient monitoring solutions. In terms of mergers and acquisitions, no recent deals have been reported involving major players in the market such as Roche Diagnostics, Takeda Pharmaceutical, or Medtronic, within the last three months.

    The market's growth has been further fueled by an increased emphasis on telehealth services, establishing a broad market valuation opportunity for companies like Abbott Laboratories and Baxter International. Moreover, Welch Allyn’s partnerships with healthcare providers aim to enhance the accessibility of testing devices, reflecting a broader trend towards improved healthcare delivery models. Over the past couple of years, particularly from January 2021 to October 2023, the market has undergone transformation influenced by regulatory support for electronic health records and the push for integrated health solutions across the United States.

    Future Outlook

    US Blood Pressure Test Market Future Outlook

    The blood pressure-test market is projected to grow at a 9.31% CAGR from 2024 to 2035, driven by technological advancements, increasing health awareness, and aging populations.

    New opportunities lie in:

    • Development of AI-driven diagnostic tools for remote monitoring.
    • Expansion of subscription-based home testing services.
    • Partnerships with telehealth platforms for integrated care solutions.

    By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

    Market Segmentation

    US Blood Pressure Test Market Product Outlook

    • sphygmomanometers
    • blood pressure transducers
    • blood pressure instrument accessories
    • others

    US Blood Pressure Test Market End User Outlook

    • hospitals & clinics
    • diagnostic centers
    • home care
    • others

    US Blood Pressure Test Market Indication Outlook

    • hypertension
    • coronary heart disease
    • others

    Report Scope

    MARKET SIZE 2024417.9(USD Million)
    MARKET SIZE 2025456.81(USD Million)
    MARKET SIZE 20351112.58(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR)9.31% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Million
    Key Companies Profiled["Omron Healthcare (JP)", "Philips (NL)", "A&D Company (JP)", "Welch Allyn (US)", "Microlife (CH)", "Beurer (DE)", "SunTech Medical (US)", "Qardio (US)", "Withings (FR)"]
    Segments CoveredProduct, Indication, End User
    Key Market OpportunitiesIntegration of telehealth solutions enhances accessibility and monitoring in the blood pressure-test market.
    Key Market DynamicsTechnological advancements and regulatory changes drive innovation in the blood pressure-test market, enhancing consumer accessibility and accuracy.
    Countries CoveredUS

    Leave a Comment

    FAQs

    What is the expected market size of the US Blood Pressure Test Market in 2024?

    The US Blood Pressure Test Market is expected to be valued at 480.0 million USD in 2024.

    What is the projected market size for the US Blood Pressure Test Market by 2035?

    By 2035, the US Blood Pressure Test Market is projected to reach a value of 1170.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Blood Pressure Test Market from 2025 to 2035?

    The expected CAGR for the US Blood Pressure Test Market from 2025 to 2035 is 8.437%.

    What are the main product segments in the US Blood Pressure Test Market?

    The main product segments in the US Blood Pressure Test Market include sphygmomanometers, blood pressure transducers, and instrument accessories.

    How is the sphygmomanometers segment expected to perform by 2035?

    The sphygmomanometers segment is expected to be valued at 400.0 million USD by 2035.

    What is the expected market value for blood pressure transducers in 2024?

    The blood pressure transducers segment is expected to be valued at 150.0 million USD in 2024.

    How much is the instrument accessories segment projected to grow by 2035?

    The instrument accessories segment is projected to grow to 420.0 million USD by 2035.

    Who are the major players in the US Blood Pressure Test Market?

    Some major players in the US Blood Pressure Test Market include Omron Healthcare, HillRom Holdings, and Roche Diagnostics, among others.

    What are the growth drivers for the US Blood Pressure Test Market?

    Key growth drivers for the US Blood Pressure Test Market include an increasing prevalence of hypertension and a growing aging population.

    What challenges does the US Blood Pressure Test Market currently face?

    Challenges facing the US Blood Pressure Test Market include regulatory hurdles and competition among various manufacturers.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions